12.06
price down icon3.44%   -0.43
pre-market  Vorhandelsmarkt:  11.95   -0.11   -0.91%
loading
Schlusskurs vom Vortag:
$12.49
Offen:
$12.52
24-Stunden-Volumen:
2.78M
Relative Volume:
0.88
Marktkapitalisierung:
$1.38B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-5.9703
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
-6.22%
1M Leistung:
-15.66%
6M Leistung:
+16.07%
1J Leistung:
-47.50%
1-Tages-Spanne:
Value
$11.96
$12.65
1-Wochen-Bereich:
Value
$11.96
$13.50
52-Wochen-Spanne:
Value
$6.78
$23.07

10 X Genomics Inc Stock (TXG) Company Profile

Name
Firmenname
10 X Genomics Inc
Name
Telefon
(925) 401-7300
Name
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Mitarbeiter
1,306
Name
Twitter
@10xgenomics
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
TXG's Discussions on Twitter

Vergleichen Sie TXG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
TXG
10 X Genomics Inc
12.06 1.55B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
277.94 45.70B 2.97B 809.93M 1.33B 4.87
Health Information Services icon
TEM
Tempus Ai Inc
79.23 14.62B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
74.27 13.84B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
94.26 8.09B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
37.04 6.58B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-11 Eingeleitet Piper Sandler Neutral
2025-02-13 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-22 Hochstufung Jefferies Hold → Buy
2024-07-18 Herabstufung JP Morgan Overweight → Neutral
2024-07-10 Herabstufung Deutsche Bank Buy → Hold
2024-06-27 Herabstufung Wolfe Research Outperform → Peer Perform
2024-06-25 Herabstufung Guggenheim Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Hold
2024-05-01 Herabstufung TD Cowen Buy → Hold
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Hochstufung BofA Securities Underperform → Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-10 Eingeleitet Barclays Overweight
2023-03-31 Eingeleitet Stephens Overweight
2023-02-02 Eingeleitet UBS Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-08-18 Herabstufung Goldman Neutral → Sell
2022-07-25 Eingeleitet Canaccord Genuity Buy
2022-07-15 Herabstufung BofA Securities Neutral → Underperform
2022-07-15 Herabstufung William Blair Outperform → Mkt Perform
2021-10-15 Fortgesetzt Cowen Outperform
2021-09-14 Herabstufung BofA Securities Buy → Neutral
2021-03-15 Eingeleitet William Blair Outperform
2020-12-02 Eingeleitet Goldman Neutral
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-07-10 Eingeleitet Stifel Buy
2020-03-05 Eingeleitet Guggenheim Buy
2020-01-07 Eingeleitet Citigroup Buy
2019-10-07 Eingeleitet BofA/Merrill Buy
2019-10-07 Eingeleitet Cowen Outperform
2019-10-07 Eingeleitet JP Morgan Overweight
2019-09-24 Eingeleitet Evercore ISI Outperform
Alle ansehen

10 X Genomics Inc Aktie (TXG) Neueste Nachrichten

pulisher
Sep 24, 2025

10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st

Sep 24, 2025
pulisher
Sep 23, 2025

78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat

Sep 23, 2025
pulisher
Sep 21, 2025

Goldman Sachs Group Inc. Has $5.63 Million Holdings in 10x Genomics $TXG - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk Hedge: Does 10x Genomics Inc. offer margin of safety2025 Earnings Impact & Growth Focused Investment Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Kera Capital Partners Inc. Buys Shares of 31,018 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Acadian Asset Management LLC Acquires 254,607 Shares of 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Investment Report: Does Future FinTech Group Inc have consistent dividend growthJuly 2025 Outlook & Precise Swing Trade Entry Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Trends: Is 10x Genomics Inc. stock a good pick for beginners2025 Key Lessons & Risk Controlled Swing Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Can 10x Genomics Inc stock outperform in a bear market2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Breakouts Watch: Can 10x Genomics Inc. sustain earnings growth2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Can 10x Genomics Inc be the next market leader2025 Momentum Check & Free High Return Stock Watch Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Risks Report: Will 10x Genomics Inc outperform its industry peersOil Prices & Smart Investment Allocation Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 4,987,195 Shares of 10x Genomics $TXG - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Institution Moves: Can 10x Genomics Inc withstand a market correction2025 Historical Comparison & Stepwise Trade Execution Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Short Squeeze: Will 10x Genomics Inc. benefit from rising consumer demandJuly 2025 Levels & AI Powered Market Trend Analysis - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Targets Report: What is the long term forecast for Malibu Boats Inc. stockPortfolio Return Summary & Advanced Technical Analysis Signals - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Momentum: Can 10x Genomics Inc outperform in the next rallyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

10x Genomics (NASDAQ:TXG) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

New Highs: Is 10x Genomics Inc in a long term uptrend2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Breakout Zone: Is 10x Genomics Inc in a long term uptrendDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Amundi Has $2.55 Million Position in 10x Genomics $TXG - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Aug Spikes: What analysts say about Rani Therapeutics Holdings Inc. stockWeekly Trade Report & Intraday High Probability Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Is 10x Genomics Inc. stock influenced by commodity pricesJuly 2025 Decliners & Expert Verified Movement Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

AQR Capital Management LLC Acquires 695,227 Shares of 10x Genomics $TXG - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Rally Mode: Can 10x Genomics Inc sustain its profitability2025 Top Decliners & Weekly Setup with High ROI Potential - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

10x Genomics (NASDAQ:TXG) Earns Neutral Rating from Analysts at Piper Sandler - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Fed Impact: Is United Fire Group Inc. forming bullish engulfing patternsGold Moves & Fast Moving Trade Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Buy Signal: Can 10x Genomics Inc sustain earnings growthJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Buyback Watch: Is 10x Genomics Inc still a buy after recent gainsJuly 2025 Intraday Action & Low Drawdown Trading Strategies - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

10x Genomics: Surprise Profitability May Be Temporary, But It's Still A Welcome Sign - Seeking Alpha

Sep 16, 2025
pulisher
Sep 16, 2025

Travel Stocks: What dividend growth rate does NOMD offerJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Market Fear: Is 10x Genomics Inc stock a good pick for beginnersJuly 2025 Reactions & Free Fast Entry Momentum Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Weekly Recap: Can 10x Genomics Inc withstand a market correctionDip Buying & High Conviction Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Risk On: Can 10x Genomics Inc deliver consistent dividendsQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug PostEarnings: Can 10x Genomics Inc sustain its profitabilityDay Trade & Real-Time Market Sentiment Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Movers: Can 10x Genomics Inc sustain its profitabilityJuly 2025 Review & Fast Gain Stock Trading Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Trading Recap: How much upside does 10x Genomics Inc. haveWeekly Gains Report & Safe Entry Zone Identification - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Valuation Update: Can 10x Genomics Inc. be the next market leader2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Voleon Capital Management LP Acquires 82,857 Shares of 10x Genomics $TXG - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Millennium Management LLC Has $46.95 Million Stock Holdings in 10x Genomics $TXG - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Caxton Associates LLP Purchases New Position in 10x Genomics $TXG - MarketBeat

Sep 13, 2025
pulisher
Sep 13, 2025

Jacobs Levy Equity Management Inc. Increases Stock Position in 10x Genomics $TXG - MarketBeat

Sep 13, 2025
pulisher
Sep 13, 2025

10x Genomics (NASDAQ:TXG) Cut to “Hold” at Wall Street Zen - Defense World

Sep 13, 2025
pulisher
Sep 12, 2025

Can trapped investors hope for a rebound in 10x Genomics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

10x Genomics (TXG) Stock Trades Down, Here Is Why - FinancialContent

Sep 12, 2025
pulisher
Sep 12, 2025

10x Genomics $TXG Shares Purchased by Amundi - Defense World

Sep 12, 2025
pulisher
Sep 12, 2025

10x Genomics (NASDAQ:TXG) Now Covered by Analysts at Piper Sandler - Defense World

Sep 12, 2025
pulisher
Sep 11, 2025

10x Genomics (TXG) Stock Is Up, What You Need To Know - Yahoo Finance

Sep 11, 2025

Finanzdaten der 10 X Genomics Inc-Aktie (TXG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

10 X Genomics Inc-Aktie (TXG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Taich Adam
Chief Financial Officer
Aug 22 '25
Sale
13.79
22,315
307,657
309,273
Hindson Benjamin J.
See Remarks
Aug 22 '25
Sale
13.79
7,486
103,209
440,888
$11.46
price down icon 1.21%
$27.79
price down icon 0.57%
$23.34
price down icon 0.60%
$34.49
price down icon 3.85%
$27.23
price down icon 2.68%
health_information_services WAY
$37.04
price down icon 1.93%
Kapitalisierung:     |  Volumen (24h):